BPaL/BpaLM regimen: A bright future for drug–resistant tuberculosis

Oki Nugraha Putra; Telly Purnamasari

doi:10.4103/apjtm.apjtm_244_24

Asian Pacific Journal of Tropical Medicine ›› 2024, Vol. 17 ›› Issue (8) :335 -337. DOI: 10.4103/apjtm.apjtm_244_24

Perspective

research-article

BPaL/BpaLM regimen: A bright future for drug–resistant tuberculosis

Oki Nugraha Putra ¹
, Telly Purnamasari ²

Author information +

History +

PDF (202KB)

Cite this article

Download citation ▾

Oki Nugraha Putra, Telly Purnamasari. BPaL/BpaLM regimen: A bright future for drug–resistant tuberculosis. Asian Pacific Journal of Tropical Medicine, 2024, 17 (8) : 335-337 DOI:10.4103/apjtm.apjtm_244_24

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	World Health Organization. Consolidated guidelines on tuberculosis Module 4: Treatment drug-resistant tuberculosis treatment 2022 update. Geneva: World Health Organization; 2022.

[2]	Nyang’wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, et al. A 24-week, all-oral regimen for rifampin-resistant tuberculosis. New Engl J Med 2022; 387(25): 2331-2343.

[3]	Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, et al. Treatment of highly drug-resistant pulmonary tuberculosis. New Engl J Med 2020; 382(10): 893-902.

[4]

Hasan T, Medcalf E, Nyang’wa BT, Egizi E, Berry C, Dodd M, et al. The safety and tolerability of linezolid in novel short-course regimens containing bedaquiline, pretomanid, and linezolid to treat rifampicin-resistant tuberculosis: An individual patient data meta-analysis. Clin Infect Dis 2023; 78(3): 730-741.

[5]

Ministry of Health of the Indonesia Republic. Handbook of operational-treatment for drug–resistant tuberculosis with BPaL/M regimen. 2023. [Online]. Available from: https://tbindonesia.or.id/wp-content/uploads/2024/02/BUKU-PEGANGAN-OPERASIONAL-PENGOBATAN-TBC-RO-PADUAN-BaPL_M-2024.pdf. [Accessed on 9 April 2024].

[6]	Sangsayunh P, Sanchat T, Chuchottaworn C, Cheewakul K, Rattanawai S. The use of BPaL containing regimen in the MDR/PreXDR TB treatments in Thailand. J Clin Tuberc Other Mycobact Dis 2024; 34: 100408.

[7]	Putra ON, Yulistiani Y, Soedarsono S, Subay S. Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis. Asian Pac J Trop Med 2023; 16(4): 169-175.